Last Updated: 08/02/2021 by Bryan Higgins
In 2018, a $25,000 grant was awarded to Dr. Mojgan Rastegar to study the role of metformin (a current and commonly available drug, used most frequently in the treatment in diabetes) as a potential therapeutic agent in the treatment of Rett Syndrome.
Last Updated: 08/02/2021 by Bryan Higgins
Dr. Mojgan Rastegar
In 2018, a $25,000 grant was awarded to Dr. Mojgan Rastegar to study the role of metformin (a current and commonly available drug, used most frequently in the treatment in diabetes) as a potential therapeutic agent in the treatment of Rett Syndrome.